
StrataXRT for the prevention of acute radiation dermatitis in breast cancer
Samantha K. F. Kennedy, et al. (2024). StrataXRT for the prevention of acute radiation dermatitis in breast cancer: A pilot study. Supportive Care in Cancer, 32(670)
Read the studyView the original website summary
“StrataXRT® is effective in preventing grade 3 radiation dermatitis in patients, and the most promising results were observed within the prone cohort.”
































